We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Simple Blood Test Measures Repetitive DNA for Early Cancer Detection

By LabMedica International staff writers
Posted on 05 Mar 2024
Print article
Image: The machine learning model detects a small, previously overlooked family of repetitive DNA (Photo courtesy of 123RF)
Image: The machine learning model detects a small, previously overlooked family of repetitive DNA (Photo courtesy of 123RF)

Cancer patients can have varying levels of a specific kind of repetitive DNA known as Alu elements in comparison to those without cancer. Despite constituting about 11% of the DNA in humans and other primates, Alu elements have traditionally been considered too complex to be effectively utilized as biomarkers due to their small, repetitive nature. Now, advancements in machine learning can allow for the measurement of these elements through a simple blood draw.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) leveraged this insight to improve a test designed for early cancer detection. They began their study with a sample size that was ten times larger than what is usually seen in such research. Alu elements are relatively small, each being about 300 base pairs in length within the vast 2 billion-step DNA ladder. Yet, changes in the proportion of Alu elements in blood plasma are consistent, irrespective of the cancer’s origin. The research team had previously developed a test for detecting aneuploidy, a condition involving chromosome copy number alterations common in cancers, using a liquid biopsy blood test. This test identifies fragments of cancer cell DNA circulating in the bloodstream. While conducting this research, they noticed an unusual signal that differentiated between cancer and non-cancer, which wasn’t attributed to changes in chromosome numbers. Consequently, they combined their original test, which analyzed 350,000 repetitive DNA locations, with an unbiased machine learning approach.

In their study, the team analyzed samples from 3,105 individuals with solid tumors and 2,073 without cancer, covering 11 types of cancer and evaluating 7,615 blood samples. The repetitive DNA sequences were examined repeatedly to assess the accuracy of the model. They achieved a specificity rate of 98.9%, crucial for minimizing false positives, especially when screening asymptomatic individuals to avoid erroneous cancer diagnoses. In an independent validation set, incorporating Alu elements into the machine learning model identified 41% of cancer cases that were missed by eight existing biomarkers and the team’s earlier test. The most significant contributor to cancer detection was identified as AluS, the largest subfamily of Alu elements. People with cancer were found to have lower levels of AluS in their blood plasma than typical. The researchers expect their Alu-based cancer detection method to complement the array of existing cancer diagnostic tools. Their next step involves identifying the most promising biomarkers and combining them for enhanced efficacy.

Related Links:
Johns Hopkins Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Plasma Control
Plasma Control Level 1

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.